Interesting that time to progression in liver was very similar to OS in this study. Would be nice to know the OS for SIrflox on current data, but looks like we may have to wait for this.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
